据报导,2024年10月30日下午盘中,Pulse Biosciences,Inc.(PLSE)股价出现大涨,最高涨幅达6.10%,引起了投资者的广泛关注。
作为一家致力于研发创新生物医疗技术的公司,Pulse Biosciences的主要产品是采用"纳米脉冲刺激(NPS)"技术的医疗设备。这种技术利用纳秒级的电能脉冲去"清除"目标细胞,同时不影响周围正常组织,在治疗多种疾病方面具有广阔的应用前景。
分析人士指出,尽管公司目前处于研发阶段尚未产生营收,但投资者对纳米脉冲技术的长期发展潜力持看好态度。与此同时,随着美股医疗设备行业整体向好,有助于提振Pulse Biosciences等科技创新型公司的投资热情。因此,该股当日出现大涨行情,但具体导火索仍有待进一步了解。不过即使如此,股价暴涨幅度也显示出市场对该公司前景的乐观预期,未来其技术取得重大进展可能进一步助涨股价。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.